Do not stop or change your medication without speaking to a pharmacist or healthcare professional.
Permanently Discontinued

NIASTASE RT

NOVO NORDISK CANADA INC

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is NIASTASE RT discontinued in Canada?

Yes. The manufacturer has reported to Health Canada that NIASTASE RT 5MG has been permanently discontinued (last updated October 31, 2017). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.

Why is NIASTASE RT not available?

The reason the manufacturer reported: Business reasons.

Can I still get this?Possibly — same-ingredient product records found
StatusPermanently Discontinued
Same-ingredient products on file2 products
Affected strength5MG
Last updated2017-10-31

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Other Products

NIASTASE

NOVO NORDISK CANADA INC

1.2MG · DIN 02239659

Different strengthDifferent dosage formSame routeNo current shortage

NIASTASE RT

NOVO NORDISK CANADA INC

8MG · DIN 02365669

Different strengthDifferent dosage formSame routeNo current shortage

What this means

Does this mean I need to switch medications right away?

Not necessarily right away, but this product will not be returning to the market.

What should I do?

Talk to your pharmacist or prescriber about your options well before your current supply runs out.

DIN

02347148

Strength

5MG

Dosage Form

KIT POWDER FOR SOLUTION

Route

INTRAVENOUS

Active Ingredient

EPTACOG ALFA

See all EPTACOG ALFA products →

Shortage History